CASE REPORTS IN ONCOLOGICAL MEDICINE
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
- PublisherHINDAWI LTD
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 725
- Publication Time16
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2011
- Publisher URL
- Website URL
- Other charges
- Plagiarism
- Publication Time16
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY
- OA statement
| Months | % Papers published |
|---|---|
| 0-3 | 33% |
| 4-6 | 37% |
| 7-9 | 26% |
| >9 | 4% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has CASE REPORTS IN ONCOLOGICAL MEDICINE been publishing? 
The CASE REPORTS IN ONCOLOGICAL MEDICINE has been publishing since 2011 till date.
How frequently is the CASE REPORTS IN ONCOLOGICAL MEDICINE published?
CASE REPORTS IN ONCOLOGICAL MEDICINE is published Continuous publication.
Who is the publisher of CASE REPORTS IN ONCOLOGICAL MEDICINE?
The publisher of CASE REPORTS IN ONCOLOGICAL MEDICINE is HINDAWI LTD.
How can I view the journal metrics of CASE REPORTS IN ONCOLOGICAL MEDICINE on editage?
For the CASE REPORTS IN ONCOLOGICAL MEDICINE metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of CASE REPORTS IN ONCOLOGICAL MEDICINE?
The eISSN number is 2090-6714 and pISSN number is 2090-6706 for CASE REPORTS IN ONCOLOGICAL MEDICINE.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Skin cancer, Immunotherapy, Rare case, Neurofibromatosis, Hemophagocytic lymphohistiocytosis, B-cell lymphoma, Pancreas, Receptor antibody, Melanoma, Hepatocellular carcinoma, Renal carcinoma, Breast cancer, Pancreatic cancer, Esophageal adenocarcinoma, Pleural effusion, Nivolumab, Langerhans cell histiocytosis, Mantle cell lymphoma, Osimertinib, Percutaneous hepatic perfusion.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.